DBV Technologies (DBVT) Accounts Payables (2015 - 2026)
DBV Technologies (DBVT) reported Accounts Payables of $39.5 million for Q1 2026, up 15.68% year-over-year from $34.1 million in Q1 2025, and down 3.42% on a QoQ basis from $40.9 million in Q4 2025.
DBV Technologies (DBVT) has 12 years of Accounts Payables data on file, last reported at $39.5 million in Q1 2026.
- Quarterly Accounts Payables rose 15.68% year-over-year to $39.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $39.5 million (up 15.68% YoY) and the FY2025 annual result came in at $40.9 million, up 85.64% from the prior year.
- Accounts Payables retreated to $39.5 million in Q1 2026 per DBVT's latest filing, from $40.9 million in the prior quarter.
- Across five years, Accounts Payables topped out at $40.9 million in Q4 2025 and bottomed at $11.4 million in Q1 2022.
- The 5-year median for Accounts Payables is $19.9 million (2023), against an average of $24.4 million.
- The widest annual swing landed in 2022, when Accounts Payables plunged 33.54%; it then soared 105.83% in 2025.
- Tracing DBVT's Accounts Payables over 5 years: stood at $14.5 million in 2022, then soared by 61.0% to $23.3 million in 2023, then fell by 5.45% to $22.0 million in 2024, then jumped by 85.64% to $40.9 million in 2025, then fell by 3.42% to $39.5 million in 2026.
- Per Business Quant, the three latest DBVT Accounts Payables figures stand at $39.5 million (Q1 2026), $40.9 million (Q4 2025), and $39.8 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1.05 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 83.00 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 10.62 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 8.64 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 489.30 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.03 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 126.63 Mn |
| 10 | DBV Technologies | 8.00 Bn | 7.77 Bn | -3.90 Mn | 39.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 39.50 Mn |
| Dec 31, 2025 | 40.90 Mn |
| Sep 30, 2025 | 39.82 Mn |
| Jun 30, 2025 | 40.79 Mn |
| Mar 31, 2025 | 34.15 Mn |
| Dec 31, 2024 | 22.03 Mn |
| Sep 30, 2024 | 22.50 Mn |
| Jun 30, 2024 | 19.82 Mn |
| Mar 31, 2024 | 18.08 Mn |
| Dec 31, 2023 | 23.30 Mn |
| Sep 30, 2023 | 16.65 Mn |
| Jun 30, 2023 | 19.09 Mn |
| Mar 31, 2023 | 19.94 Mn |
| Dec 31, 2022 | 14.47 Mn |
| Sep 30, 2022 | 15.37 Mn |
| Jun 30, 2022 | 16.34 Mn |
| Mar 31, 2022 | 11.42 Mn |
| Dec 31, 2021 | 11.43 Mn |
| Sep 30, 2021 | 12.17 Mn |
| Jun 30, 2021 | 16.34 Mn |
| Mar 31, 2021 | 17.18 Mn |
| Dec 31, 2020 | 20.34 Mn |
| Jun 30, 2020 | 24.14 Mn |
| Dec 31, 2019 | 23.65 Mn |
| Sep 30, 2019 | -12.09 Mn |
| Jun 30, 2019 | -6.68 Mn |
| Dec 31, 2018 | 32.61 Mn |
| Sep 30, 2018 | 1.09 Mn |
| Jun 30, 2018 | 3.35 Mn |
| Dec 31, 2017 | 19.95 Mn |
| Jun 30, 2017 | 16.79 Mn |
| Dec 31, 2016 | 3.94 Mn |
| Dec 31, 2015 | 11.00 Mn |